References
- Biemar F, Foti M. Global progress against cancer-challenges and opportunities. Cancer Biol Med. 2013;10(4):183–6. doi:https://doi.org/10.7497/j.issn.2095-3941.2013.04.001
- Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the Human Development Index (2008–2030): a population-based study. Lancet Oncol. 2012;13(8):790–801. doi:https://doi.org/10.1016/S1470-2045(12)70211-5
- Koehn FE, Carter GT. The evolving role of natural products in drug discovery. Nat Rev Drug Discov. 2005;4(3):206–20. doi:https://doi.org/10.1038/nrd1657
- Foo J, Michor F. Evolution of acquired resistance to anti-cancer therapy. J Theor Biol. 2014;355:10–20. doi:https://doi.org/10.1016/j.jtbi.2014.02.025
- Iacobucci I, Mullighan CG. Genetic basis of acute lymphoblastic leukemia. J Clin Oncol. 2017;35(9):975–83. doi:https://doi.org/10.1200/JCO.2016.70.7836
- Raetz EA, Teachey DT. T-cell acute lymphoblastic leukemia. Hematol Am Soc Hematol Educ Program. 2016;2016(1):580–8. doi:https://doi.org/10.1182/asheducation-2016.1.580
- Reismüller B, Attarbaschi A, Peters C, Dworzak MN, Pötschger U, Urban C, Fink F-M, Meister B, Schmitt K, Dieckmann K, Austrian Berlin-Frankfurt-Münster (BFM) Study Group, et al. Long-term outcome of initially homogenously treated and relapsed childhood acute lymphoblastic leukaemia in Austria-a population-based report of the Austrian Berlin-Frankfurt-Münster (BFM) Study Group. Br J Haematol. 2009;144(4):559–70. doi:https://doi.org/10.1111/j.1365-2141.2008.07499.x
- Raetz EA, Borowitz MJ, Devidas M, Linda SB, Hunger SP, Winick NJ, Camitta BM, Gaynon PS, Carroll WL. Reinduction platform for children with first marrow relapse of acute lymphoblastic Leukemia: A Children’s Oncology Group Study[corrected]. JCO. 2008;26(24):3971–8. doi:https://doi.org/10.1200/JCO.2008.16.1414
- Moghadam MH, Hajimehdipoor H, Saeidnia S, Atoofi A, Shahrestani R, Read RW, Mosaddegh M. Anti-proliferative activity and apoptotic potential of britannin, a sesquiterpene lactone from Inula aucheriana. Nat Prod Commun. 2012;7(8):1934578X1200700. doi:https://doi.org/10.1177/1934578X1200700804
- Moeinifard M, Hassan ZM, Fallahian F, Hamzeloo-Moghadam M, Taghikhani M. Britannin induces apoptosis through AKT-FOXO1 pathway in human pancreatic cancer cells. Biomed Pharmacother. 2017;94:1101–10. doi:https://doi.org/10.1016/j.biopha.2017.08.025
- Yan G, Guo Y, Guo J, Wang Q, Wang C, Wang X. N-Acetylcysteine Attenuates Lipopolysaccharide-induced osteolysis by restoring bone remodeling balance via reduction of reactive oxygen species formation during osteoclastogenesis. Inflammation. 2020;43(4):1279. doi:https://doi.org/10.1007/s10753-020-01207-y
- Xu, R., et al. The clinical value of using chloroquine or hydroxychloroquine as autophagy inhibitors in the treatment of cancers: a systematic review and meta-analysis. Medicine, 2018;97(46. doi:https://doi.org/10.1097/MD.0000000000012912
- Lin Y-C, Lin J-F, Wen S-I, Yang S-C, Tsai T-F, Chen H-E, Chou K-Y, Hwang TI-S. Chloroquine and hydroxychloroquine inhibit bladder cancer cell growth by targeting basal autophagy and enhancing apoptosis. Kaohsiung J Med Sci. 2017;33(5):215–23. doi:https://doi.org/10.1016/j.kjms.2017.01.004
- Purizaca J, Contreras-Quiroz A, Dorantes-Acosta E, Vadillo E, Arriaga-Pizano L, Fuentes-Figueroa S, Villagomez-Barragán H, Flores-Guzmán P, Alvarado-Moreno A, Mayani H, et al. Lymphoid progenitor cells from childhood acute lymphoblastic leukemia are functionally deficient and express high levels of the transcriptional repressor Gfi-1. Clin Dev Immunol. 2013;2013:349067. doi:https://doi.org/10.1155/2013/349067
- Terwilliger T, Abdul-Hay M. Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J. 2017;7(6):e577. doi:https://doi.org/10.1038/bcj.2017.53
- Siegel DA, Henley SJ, Li J, Pollack LA, Van Dyne EA, White A. Rates and trends of pediatric acute lymphoblastic leukemia—United States, 2001–2014. MMWR Morb Mortal Wkly Rep. 2017;66(36):950–4. doi:https://doi.org/10.15585/mmwr.mm6636a3
- Sitaresmi MN, et al. Chemotherapy-related side effects in childhood acute lymphoblastic leukemia in Indonesia: parental perceptions. J Pediatr Oncol Nurs. 2009;26(4):198–207. doi:https://doi.org/10.1177/1043454209340315
- Lowas SR, Marks D, Malempati S. Prevalence of transient hyperglycemia during induction chemotherapy for pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer. 2009;52(7):814–8. doi:https://doi.org/10.1002/pbc.21980
- Gali-Muhtasib H, Hmadi R, Kareh M, Tohme R, Darwiche N. Cell death mechanisms of plant-derived anticancer drugs: beyond apoptosis. Apoptosis. 2015;20(12):1531–62. doi:https://doi.org/10.1007/s10495-015-1169-2
- Jiang Q-L, Zhang S, Tian M, Zhang S-Y, Xie T, Chen D-Y, Chen Y-J, He J, Liu J, Ouyang L, et al. Plant lectins, from ancient sugar‐binding proteins to emerging anti‐cancer drugs in apoptosis and autophagy. Cell Prolif. 2015;48(1):17–28. doi:https://doi.org/10.1111/cpr.12155
- Maddika S, Ande SR, Panigrahi S, Paranjothy T, Weglarczyk K, Zuse A, Eshraghi M, Manda KD, Wiechec E, Los M, et al. Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy. Drug Resist Updat. 2007;10(1–2):13–29. doi:https://doi.org/10.1016/j.drup.2007.01.003
- Coqueret O. New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment?Trends Cell Biol. 2003;13(2):65–70. doi:https://doi.org/10.1016/S0962-8924(02)00043-0
- Hamzeloo-Moghadam M, Aghaei M, Abdolmoham Madi MH, Fallahian F. Anticancer activity of britannin through the downregulation of cyclin D1 and CDK4 in human breast cancer cells. J Cancer Res Ther. 2019;15(5):1105–8. doi:https://doi.org/10.4103/jcrt.JCRT_517_17
- Tapon N, Harvey KF, Bell DW, Wahrer DCR, Schiripo TA, Haber DA, Hariharan IK. salvador Promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines. Cell. 2002;110(4):467–78. doi:https://doi.org/10.1016/S0092-8674(02)00824-3
- Darzynkiewicz Z, Bruno S, Del Bino G, Gorczyca W, Hotz MA, Lassota P, Traganos F. Features of apoptotic cells measured by flow cytometry. Cytometry. 1992;13(8):795–808. doi:https://doi.org/10.1002/cyto.990130802
- Cui Y-Q, Liu Y-J, Zhang F. The suppressive effects of Britannin (Bri) on human liver cancer through inducing apoptosis and autophagy via AMPK activation regulated by ROS. Biochem Biophys Res Commun. 2018;497(3):916–23. doi:https://doi.org/10.1016/j.bbrc.2017.12.144
- Lozy F, Karantza V. Autophagy and cancer cell metabolism. In Seminars in cell & developmental biology. Academic Press Ltd-Elsevier Science Ltd; 2012. doi:https://doi.org/10.1016/j.semcdb.2012.01.005
- Kang R, Zeh HJ, Lotze MT, Tang D. The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ. 2011;18(4):571–80. doi:https://doi.org/10.1038/cdd.2010.191
- Matés JM, Segura JA, Alonso FJ, Márquez J. Intracellular redox status and oxidative stress: implications for cell proliferation, apoptosis, and carcinogenesis. Arch Toxicol. 2008;82(5):273–99. doi:https://doi.org/10.1007/s00204-008-0304-z
- Chen A, Chen Z, Xia Y, Lu D, Yang X, Sun A, Zou Y, Qian J, Ge J. Liraglutide attenuates NLRP3 inflammasome-dependent pyroptosis via regulating SIRT1/NOX4/ROS pathway in H9c2 cells. Biochem Biophys Res Commun. 2018;499(2):267–72. doi:https://doi.org/10.1016/j.bbrc.2018.03.142
- Das TP, Suman S, Alatassi H, Ankem MK, Damodaran C. Inhibition of AKT promotes FOXO3a-dependent apoptosis in prostate cancer. Cell Death Dis. 2016;7(2):e2111. doi:https://doi.org/10.1038/cddis.2015.403